ストックスクリーナーアプリを入手
8.8383
1.12%
0.0983
前日終値:
$8.74
開ける：
$8.84
24時間の取引高:
6,051
Relative Volume:
0.08
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-3.32%
1か月 パフォーマンス:
-10.81%
6か月 パフォーマンス:
-22.06%
1年 パフォーマンス:
-22.27%
1日の値動き範囲:
$8.81
$8.90
1週間の範囲:
$8.59
$9.0479
52週間の値動き範囲:
$8.59
$11.88
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
GNOM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
8.85 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
276.35 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
561.65 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
564.31 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
222.89 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
478.65 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf (GNOM) 最新ニュース
SBI Securities Co. Ltd. Purchases Shares of 5,170 Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Sanctuary Advisors LLC Takes $104,000 Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value the Markets
Grid Metals (CVE:GRDM) Given a C$0.42 Price Target at Fundamental Research - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stake Reduced by Stratos Wealth Partners LTD. - Defense World
(GNOM) On The My Stocks Page - Stock Traders Daily
Top Canadian Genetics Stocks of 2025 - The Motley Fool Canada
(GNOM) Trading Advice - Stock Traders Daily
How To Trade (GNOM) - Stock Traders Daily
Stifel Financial Corp Reduces Stock Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Jane Street Group LLC Sells 16,550 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Learn to Evaluate (GNOM) using the Charts - Stock Traders Daily
Rockefeller Capital Management L.P. Acquires Shares of 18,186 Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Five Thematic Trends to Watch in 2025 - Saxo Bank
Best-Performing ETF Areas of Last Week - Yahoo Finance
Atria Investments Inc Invests $122,000 in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
When (GNOM) Moves Investors should Listen - Stock Traders Daily
Top Tech ETFs Right Now - Benzinga
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
Newport Capital Group LLC Acquires Shares of 21,305 iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI) - Defense World
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
How To Avoid The Worst Sector ETFs 3Q24 - Forbes
Investing in Nobel Prize Achievements – CRISPR For Precise Genetic Engineering - Securities.io
3 Gene Editing Stocks with Potential to Transform Medicine - InvestorPlace
BioTech & Genomics ETFs Shine Amid Sector Rotation - Trackinsight
Biotech ETFs See Uptick Amid Positive Market Signs - Trackinsight
The 3 Best Gene Editing Stocks to Buy in July 2024 - InvestorPlace
4 Up-and-Coming Small-Cap Biotech Stocks to Watch - Investing.com
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money
The Next Big Theme: June 2024 - Global X
9 Best Biotech ETFs for 2024 - MSN
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life - Nasdaq
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire - InvestorPlace
In the Pipeline: Top Drug Candidates for FDA Approval in 2024 - Nasdaq
The Next Big Theme: April 2024 - Global X
What Is a Genomics ETF? A Complete Guide to the Breakthrough Biotech - etf.com
Investing in Pharma: How to Spot Leading Drug Candidates - Global X
CTNM Stock: Discover Biotech Investing Potential with Contineum Therapeutics - Value the Markets
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment (NASDAQ:GNOM) - Seeking Alpha
3 Stocks That Could Be the Next Big Thing in Gene Editing - InvestorPlace
The Next Big Theme: March 2024 - Global X
Why Gene Editing Could Be Worth $120 Billion by 2027 - Opto RoW
Gene Therapy: A Cure for Cancer? - Opto RoW
3 Gene Editing Stocks With Unprecedented Surge Potential - Yahoo Finance
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential - InvestorPlace
The Next Big Theme: January 2024 - Global X
3 Biotech ETFs to Bet on Now - Nasdaq
M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024 - InvestorPlace
The Next Big Theme: December 2023 - Global X
VettaFi Voices On: The Outlook for 2024 - ETF Trends
The Next Big Theme: November 2023 - Global X
Global X Genomics Biotechnology Etf (GNOM) 財務データ
Global X Genomics Biotechnology Etf (GNOM) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.35%
大文字化:
|
ボリューム (24 時間):